학술논문

PB2113: FRONTMIND: A PHASE III, RANDOMIZED, DOUBLE-BLIND STUDY OF TAFASITAMAB + LENALIDOMIDE + R-CHOP VS R-CHOP ALONE FOR NEWLY DIAGNOSED HIGH-INTERMEDIATE AND HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA
Document Type
article
Source
HemaSphere, Vol 6, Pp 1984-1985 (2022)
Subject
Diseases of the blood and blood-forming organs
RC633-647.5
Language
English
ISSN
2572-9241